Meijuan Yan Selected Research

PQQ Cofactor (Pyrroloquinoline Quinone)

1/2017	The Effect of Pyrroloquinoline Quinone on the Expression of WISP1 in Traumatic Brain Injury.
1/2017	The Effect of Pyrroloquinoline Quinone on Apoptosis and Autophagy in Traumatic Brain Injury.
3/2012	The neuroprotective effect of pyrroloquinoline quinone on traumatic brain injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meijuan Yan Research Topics

Disease

12	Inflammation (Inflammations) 09/2021 - 01/2007
4	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2017 - 02/2010
3	Neoplasms (Cancer) 10/2016 - 12/2010
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2013 - 05/2010
2	Spinal Cord Injuries (Spinal Cord Injury) 09/2021 - 05/2008
2	Hepatocellular Carcinoma (Hepatoma) 01/2014 - 04/2013
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2022
1	Sepsis (Septicemia) 01/2021
1	Cognitive Dysfunction 01/2019
1	Ganglion Cysts (Ganglion) 04/2014
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Breast Neoplasms (Breast Cancer) 12/2010
1	Autoimmune Diseases (Autoimmune Disease) 07/2010
1	Demyelinating Diseases (Demyelinating Disease) 01/2010
1	Multiple Sclerosis 01/2010
1	Sarcoma (Soft Tissue Sarcoma) 05/2009
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2008
1	Peripheral Nerve Injuries 01/2008

Drug/Important Bio-Agent (IBA)

9	Messenger RNA (mRNA)IBA 01/2022 - 01/2007
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2010 - 01/2007
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2010
3	LipopolysaccharidesIBA 09/2021 - 12/2007
3	PQQ Cofactor (Pyrroloquinoline Quinone)IBA 01/2017 - 03/2012
3	Phosphotransferases (Kinase)IBA 04/2014 - 05/2009
2	Caspase 3 (Caspase-3)IBA 01/2021 - 01/2017
2	Biological ProductsIBA 04/2014 - 04/2007
2	Small Interfering RNA (siRNA)IBA 01/2014 - 04/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2022
1	Kir2.1 channelIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Interleukin-6 (Interleukin 6)IBA 09/2021
1	pyrroloquinolineIBA 09/2021
1	Connexin 43 (Connexin43)IBA 01/2021
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019
1	perfluorooctaneIBA 01/2019
1	TransferasesIBA 01/2017
1	Lysosomal Membrane ProteinsIBA 01/2017
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 10/2016
1	COP9 Signalosome ComplexIBA 10/2016
1	Carrier Proteins (Binding Protein)IBA 10/2016
1	Annexin A2 (Annexin II)IBA 01/2014
1	GlypicansIBA 04/2013
1	Freund's AdjuvantIBA 03/2013
1	Neuroprotective AgentsIBA 03/2012
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2011
1	N-Methylaspartate (NMDA)IBA 01/2011
1	Protein Isoforms (Isoforms)IBA 01/2011
1	LigandsIBA 12/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 05/2010
1	ras ProteinsIBA 05/2010
1	Lipase (Acid Lipase)FDA Link 02/2010
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2010
1	beta-1,4-galactosyltransferase IIBA 05/2008
1	Ropivacaine (Naropin)FDA LinkGeneric 05/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2008

Therapy/Procedure

2	Intraperitoneal Injections 01/2021 - 09/2009
2	Therapeutics 04/2013 - 12/2010
1	Aftercare (After-Treatment) 01/2017
1	Nephrectomy 05/2008
1	General Anesthesia 05/2008
1	Anesthesia 05/2008